May 16, 2019
ChargePoint Technology boosts UK presence with new appointment
Contained and sterile transfer solutions expert, ChargePoint Technology, has appointed Stephen Eastick as UK Sales Manager.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
May 13, 2019
R&D in the biopharmaceutical industry is witnessing an upsurge
The traditional R&D in the biopharmaceutical industry iswitnessing an upsurge, due to drug development research, which ishelping in the augmentation of the industrial microbiology market.
May 13, 2019
North America expected to provide high business for the atopicdermatitis market 2019-2024
Food allergy has been essentially highly debatable for decades in atopicdermatitis, with some common food, including milk, egg, and soy. Thereis a lot of literature which provides evidence that common foodexacerbate atopic dermatitis.
May 13, 2019
Medivir has positive data from basal cell carcinoma study
Swedish Medivir said Monday that positive data from the investigator-initiated study of remetinostat in basal cell carcinoma (BCC) patients has shown that remetinostat gel offers a potentially effective and well-tolerated, non-surgical intervention for treatment of localized BCCs.
May 13, 2019
Transgene gets FDA IND clearance to start clinical trial of myvac for ovarian cancer treatment
Transgene can start linical trial of its lead myvac™ candidate TG4050as a potential treatment for ovarian cancer patients after first-linesurgery and chemotherapy
May 10, 2019
Vifor Pharma’s Phase-II AMBER Study Meets Primary Endpoint
phase-II AMBER study whichdemonstrated that a significantly higher proportion of patients withresistant hypertension (RHTN) and chronic kidney disease (CKD) takingVeltassa® (patiromer) remained on spironolactone therapycompared to patients taking placebo at week 12.
May 10, 2019
Global oligonucleotide synthesis market could reach $2.9billion by 2024
Global oligonucleotide synthesis market is expected to reach $2.9billion by 2024, at a CAGR of 10.5% during the forecast period of 2019to 2024.
May 10, 2019
Influenza Vaccines Market projected to exceed $6 Billion by 2025
The global influenza vaccines market size is expected to surpass USD 6billion by 2025.
May 9, 2019
Global Opioids Market – Rising Focus on Abuse-deterrent Formulation (ADF) by Generic Manufacturers
Due to an increase in the incidence of medical ailments, the marketstudied is expected to grow over the forecast period.
May 9, 2019
The $3.12Bn Global Food Enzymes Market by Source, Type, Form, Application and Geography – Forecast to 2024
The global food enzymes market is expected to grow at a CAGR of 7.5%from 2019 to reach $3,125.1 million by 2024 from $2,176.9 million in2019.